Compound Detail
CHEMBL2289201
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2289201 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZDGNASNZJSBUHL-OAHLLOKOSA-N |
6
Targets
6
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
388.5
MW (Da)
4.43
ALogP
5
HBA
0
HBD
54.7
PSA (Ų)
0.62
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 7.92
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Bel-7402 | IC50 | = | 12.0 | nM | 7.92 | Antiproliferative activity against human Bel-7402 cells after 72 hrs by SRB assa... | 31171403 |
| K562 | IC50 | = | 13.6 | nM | 7.87 | Antiproliferative activity against human K562 cells | 31171403 |
| K562/Adr | IC50 | = | 15.8 | nM | 7.8 | Antiproliferative activity against drug- resistant human K562/ADR cells | 31171403 |
| HL-60 | IC50 | = | 44.0 | nM | 7.36 | Antiproliferative activity against human HL-60 cells after 72 hrs by MTT assay | 31171403 |
| Unchecked | IC50 | = | 600.0 | nM | 6.22 | Antiproliferative activity against drug-resistant human KB/VCR cells | 31171403 |
| KB | IC50 | = | 1100.0 | nM | 5.96 | Antiproliferative activity against human KB cells | 31171403 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31171403 | 10.1016/j.bmc.2019.05.030 | Bel-7402 | 25 |
| 23320928 | 10.1021/jf304905k | Tobacco mosaic virus | 8 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | Unchecked | 8 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | KB | 3 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | K562 | 3 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | SMMC-7721 | 2 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | U-118-MG | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | HL-60 | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | K562/Adr | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | Huh-7 | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | Hep 3B2 | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | HepG2 | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | BEL-7404 tumor cell line | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | SGC-7901 | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | MKN-45 | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | T47D | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | SK-BR-3 | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | MDA-MB-231 | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | MDA-MB-157 | 1 |
| 31171403 | 10.1016/j.bmc.2019.05.030 | MCF7 | 1 |
Data from ChEMBL 36 via Core Engine